Company / News

Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)

Guidance for Industry and Food and Drug Administration Staff

FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

FDA is issuing this guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19 for the duration of the COVID-19 public health emergency.

download whitepaper

Related News

NPI Accelerator Premier Launch Event

Date: Wednesday, June 20, 2012 Time: 1:00pm to 2:00pm EDT...

Sensors, Wearable Devices, and IoT Video

Today, it is all about being connected and staying connected....

Secure-by-Design Medical IoT and Wearable Devices

How to meet FDA and CE requirements and avoid embarrassing...

Newsletter Sign Up
chat-icon
clse-1
Get Expert Consulting

Voler is really good at identifying risks and finding the best way to do a project on-time, on spec, and easy to manufacture.